European experience of bone-marrow transplantation for severe combined immunodeficiency - PubMed (original) (raw)
European experience of bone-marrow transplantation for severe combined immunodeficiency
A Fischer et al. Lancet. 1990.
Abstract
The outcome of bone-marrow transplantations (BMT) carried out between 1968 and March 1, 1989, in 183 patients with severe combined immunodeficiency (SCID) was analysed. Recipients of HLA-identical BMTs (70) had a 76% probability of survival (median follow-up 73 months). Of the 32 treated since 1983, 97% have been cured (median follow-up 41 months). This good prognosis was associated with rapid development of T and B cell function. HLA-non-identical, T-cell-depleted, BMT (n = 100) gave significantly lower survival (52%; median follow-up 47 months). Factors associated with poor prognosis were the presence of a lung infection before BMT, absence of a protected environment, and use of female donors for male recipients. Use of a conditioning regimen significantly increased the frequency of sustained engraftment (86% vs 50% for non-conditioned BMT) and resulted in more frequent engraftment of donor B lymphocytes and myeloid cells. Donor B-cell chimerism was strongly associated with the development of normal B-cell function.
Similar articles
- Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
Bertrand Y, Landais P, Friedrich W, Gerritsen B, Morgan G, Fasth A, Cavazzana-Calvo M, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Haddad E, Fischer A. Bertrand Y, et al. J Pediatr. 1999 Jun;134(6):740-8. doi: 10.1016/s0022-3476(99)70291-x. J Pediatr. 1999. PMID: 10356144 Clinical Trial. - Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A. Jabado N, et al. Pediatrics. 1996 Sep;98(3 Pt 1):420-8. Pediatrics. 1996. PMID: 8784367 - Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
Haddad E, Landais P, Friedrich W, Gerritsen B, Cavazzana-Calvo M, Morgan G, Bertrand Y, Fasth A, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Fischer A. Haddad E, et al. Blood. 1998 May 15;91(10):3646-53. Blood. 1998. PMID: 9573000 - The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease.
O'Reilly RJ, Keever CA, Small TN, Brochstein J. O'Reilly RJ, et al. Immunodefic Rev. 1989;1(4):273-309. Immunodefic Rev. 1989. PMID: 2698644 Review.
Cited by
- Personalized hematopoietic stem cell transplantation for inborn errors of immunity.
Slatter M, Lum SH. Slatter M, et al. Front Immunol. 2023 Apr 5;14:1162605. doi: 10.3389/fimmu.2023.1162605. eCollection 2023. Front Immunol. 2023. PMID: 37090739 Free PMC article. Review. - Treosulfan-based conditioning for inborn errors of immunity.
Slatter MA, Gennery AR. Slatter MA, et al. Ther Adv Hematol. 2021 May 20;12:20406207211013985. doi: 10.1177/20406207211013985. eCollection 2021. Ther Adv Hematol. 2021. PMID: 34094045 Free PMC article. Review. - Radiation-induced kidney toxicity: molecular and cellular pathogenesis.
Klaus R, Niyazi M, Lange-Sperandio B. Klaus R, et al. Radiat Oncol. 2021 Feb 25;16(1):43. doi: 10.1186/s13014-021-01764-y. Radiat Oncol. 2021. PMID: 33632272 Free PMC article. Review. - Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.
Fox TA, Chakraverty R, Burns S, Carpenter B, Thomson K, Lowe D, Fielding A, Peggs K, Kottaridis P, Uttenthal B, Bigley V, Buckland M, Grandage V, Denovan S, Grace S, Dahlstrom J, Workman S, Symes A, Mackinnon S, Hough R, Morris E. Fox TA, et al. Blood. 2018 Feb 22;131(8):917-931. doi: 10.1182/blood-2017-09-807487. Epub 2017 Dec 26. Blood. 2018. PMID: 29279357 Free PMC article. - Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.
Orozco JJ, Kenoyer A, Balkin ER, Gooley TA, Hamlin DK, Wilbur DS, Hylarides MD, Frost SH, Mawad R, O'Donnell P, Sandmaier BM, Fuchs EJ, Luznik L, Green DJ, Gopal AK, Press OW, Pagel JM. Orozco JJ, et al. Blood. 2016 Jan 21;127(3):352-9. doi: 10.1182/blood-2014-12-617019. Epub 2015 Nov 17. Blood. 2016. PMID: 26576864 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials